Shareholders approve 500,000-share increase and extension of 2015 Stock Incentive Plan to 2032

UNITED THERAPEUTICS Corp

Plan share reserve increased by 500,000 to 11.5M shares; expiration extended to April 25, 2032.
All 9 director nominees elected with majority vote; advisory say-on-pay passed with 38.9M for, 0.7M against.
Plan amendment received 34.8M votes for (85.8% of votes cast); Ernst & Young ratified as auditor for 2022.
Amendment effective June 27, 2022; prior plan was approved by shareholders in June 2021.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.